Piramal Pharma’s Loss Narrows to Rs 82 Crore in June Quarter on Improved Operating Metrics, Strong CDMO Growth
Piramal Pharma Ltd. (PPL), a key player in India’s pharmaceutical and healthcare industry, reported a consolidated net loss of Rs 82 crore in the quarter ended June 2025, a marked improvement from a net loss of Rs 131 crore in the corresponding quarter of the previous financial year. The narrowing of losses comes on the…